FUS and amyotrophic lateral sclerosis: Investigating the relative contribution of these modifier variants to disease pathogenesis is often challenging, requiring extensive experimental as well as computational genomic and bioinformatic analysis, and further work is required to elucidate the influence of such genetic modifiers on the disease course of FUS-associated ALS/FTD.